Coca-Cola bottling partner’s market operations head quits amid restructuring – Economic Times

NEW DELHI: Rohit Gothi, executive director of market operations at beverage maker Coca-Cola‘s bottling partner, has put in his papers, a month after the company announced a large-scale restructuring of its business, which would make some jobs redundant. A spokesperson for Hindustan Coca-Cola Beverages Pvt. confirmed Gothi’s resignation. “Rohit Gothi has decided to pursue a…

Apogee Announces Architectural Glass Restructuring, Will Close St. George Facility – Utah Business

St. George and MinneapolisApogee Enterprises, Inc., which provides distinctive solutions for enclosing commercial buildings and framing art, announced Friday details of the planned restructuring referenced in its December 21, 2017, third-quarter earnings release. As part of our initiatives to diversify and strengthen our business for more stable performance in any economic cycle, Apogee is making…

Heidrick & Struggles Restructuring to Strengthen Financial Performance, Realign Organization to Enhance Business … – PR Newswire (press release)

CHICAGO, Jan. 5, 2018 /PRNewswire/ — Heidrick & Struggles (Nasdaq: HSII), a premier provider of executive search, leadership assessment and development, organization and team effectiveness, and culture shaping services, today announced a restructuring plan to reduce overall costs and improve efficiencies in its operations over the next several months. The expected annual cost savings from the…

Apogee Announces Architectural Glass Restructuring – Business Wire (press release)

MINNEAPOLIS–(BUSINESS WIRE)–Apogee Enterprises, Inc. (Nasdaq:APOG), which provides distinctive solutions for enclosing commercial buildings and framing art, today announced details of the planned restructuring referenced in its December 21, 2017, third-quarter earnings release. As part of our initiatives to diversify and strengthen our business for more stable performance in any economic cycle, Apogee is making significant…

OvaScience (OVAS) Reports Update on Phase 1 Clinical Trial of OvaPrime; Announces Corporate Restructuring … – StreetInsider.com

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here. OvaScience (NASDAQ: OVAS) today provided a corporate update. The Company announced initial clinical data from its ongoing Phase 1 trial of OvaPrime in women with primary ovarian insufficiency (POI) and poor ovarian response (POR). In an interim…